Özge has a MSc. in Molecular Genetics from the University of Leicester and a PhD in Developmental Biology from Queen Mary University of London. She worked as a Post-doctoral Research Associate at the University of Leicester for six years in the field of Behavioural Neurology before moving into science communication. She worked as the Research Communication Officer at a London based charity for almost two years.
Articles by Özge Özkaya
Recent Posts
- Tavneos linked with remission in ANCA-associated vasculitis April 17, 2024
- Worse sinonasal symptoms linked to higher risk of GPA relapse April 15, 2024
- Reflecting on the stages of growth I’ve experienced with EGPA April 12, 2024
- DNA-targeting antibodies may be therapeutic options for AAV April 10, 2024
- 2 AAV types better suggest clinical features, outcomes in study April 8, 2024
- EGPA, kidney damage raise risk of blood clots in AAV patients: Study April 3, 2024
- Relapse risk not linked to plasma exchange, low-dose glucocorticoids April 1, 2024
- Creatinine levels, biopsy predict AAV kidney failure risk, study finds March 27, 2024
- GTI may help ID who’s at risk for glucocorticoid side effects March 25, 2024
- Clinical trial recruitment for povetacicept ongoing in 3 countries March 20, 2024